The COVID-19 pandemic made it clear that we need new ways of conducting clinical trials, which place less burden on participants. Even prior to COVID-19, obtaining informed consent in clinical trials required a complex, in-person process that often took hours. The administrative work and expense of maintaining paper records could be a serious drain on limited study resources.
Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key considerations for ethics board approval